MedTrace Logo

Outcome of Platelet Rich Plasma in ICSI Patients, a Randomized Controlled Trial

NCT04434495 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 788

Last updated 2020-06-17

No results posted yet for this study

Summary

2 groups randomized to PRP injectioninto uterine cavity at mock embryo transfer, and a control group with only mock embryo transfer.

Conditions

  • Pregnancy Outcome

Interventions

BIOLOGICAL

PRP

PRP injection into uterine cavity

Sponsors & Collaborators

  • Dr. Osman Hospital

    lead OTHER

Principal Investigators

  • Hisham Gouda, MD · Assistant prof Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2020-11-15
Completion
2021-04-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04434495 on ClinicalTrials.gov